Quick answer: Sermorelin is lawfully obtained online through a prescription from a licensed prescriber, filled by a state-licensed US pharmacy. FDA approved the brand Geref in 1990 and 1997, then withdrew that approval effective 2009-06-18 after the maker discontinued it. Sermorelin offered online today is a compounded medication, and compounded medications are not FDA-approved. FDA does not review them for safety, effectiveness or quality before they are sold.
This page answers one question: what does a lawful online purchase of sermorelin look like, and what has FDA actually said about it? Some links on this page are affiliate links, which means we may earn a commission if you use them. We keep the facts and the links apart, and we mark every status with its source and date.
- FDA status
Brand Geref: approval withdrawn effective 2009-06-18. Compounded sermorelin is not FDA-approved.
- Lawful route
Prescription from a licensed prescriber; the pharmacy must be state-licensed and in the US
- Brand or compounded
Compounded today. The former brand, Geref, was discontinued by its maker in 2008.
- Whoosh offers this
Yes, compounded, as stated by Whoosh (read 2026-10-07)
As of 2026-10-07. Sources are listed at the end of the page.
The lawful route in plain words
FDA's page on unapproved GLP-1 drugs states the general rule for any compounded drug: "Patients should obtain a prescription from their doctor" and fill it at a state-licensed pharmacy. FDA's online-pharmacy guidance adds three checks: the pharmacy requires a prescription, gives a physical US address and telephone number, and has a licensed pharmacist who can answer questions. It also says to confirm the license in the state board of pharmacy database and to avoid a pharmacy that is not listed.
That route has two people in it. A prescriber reviews your history and decides whether a prescription is appropriate. A pharmacy then prepares and ships it. A website that skips either step is not following the route FDA describes. Our five-point check applies the same logic to any seller, and the online prescription process page walks through what happens between the questionnaire and the box.
From Geref to compounded status
Sermorelin is unusual among popular peptides: it once had an FDA approval, and the paper trail is public. The table follows it from approval to today. Each row comes from FDA text we read directly on 2026-10-07.
| Date | What happened | Source |
|---|---|---|
| 1990-12-28 | Geref in ampules (NDA 19-863) first approved, described by FDA as a test of the pituitary gland's ability to release growth hormone | Federal Register, 2013-03-04 |
| 1997-09-26 | Geref in vials (NDA 20-443) first approved for idiopathic growth hormone deficiency (GHD) in children with growth failure | Federal Register, 2013-03-04 |
| 2008-07-11 and 2008-12-02 | The maker sent FDA letters saying the two products were being discontinued | Federal Register, 2013-03-04 |
| 2009-05-19 | FDA announced withdrawal of both approvals, effective 2009-06-18 | Federal Register, 2013-03-04 (cites 74 FR 23407) |
| 2013-02-26 | FDA determined the products "were not withdrawn from sale for reasons of safety or effectiveness" | Federal Register, 2013-03-04 |
| 2025-03-21 | FDA's 503B document lists sermorelin acetate in Category 1, "Bulk Drug Substances Under Evaluation" | FDA 503B list, updated 2025-03-21 |
| 2026-05-14 | FDA's 503A document, updated that day, has no entry for sermorelin in any category we found | FDA 503A list, updated 2026-05-14 |
As of 2026-10-07.
Three points from that table deserve plain statements.
The notice does not give a reason for the discontinuation. The 2013 Federal Register notice records the maker's letters and the withdrawal dates. It does not say why the maker stopped. Anyone who states a reason is going beyond that document, so we do not.
The 2013 finding is narrow. FDA decided that the withdrawal was not for safety or effectiveness reasons. That keeps the door open for other applications to be filed, according to the notice. It is not a statement that compounded sermorelin is approved, and it is not a statement about any product made today.
The approved uses were specific. FDA's briefing document for its October 2024 advisory committee says Geref was approved for a preselected group of children with growth hormone deficiency who respond to a stimulation test, and that no drug in this class has an approval for adult growth hormone deficiency. A reader weighing sermorelin for an adult purpose is therefore outside the approved history, which is a reason to talk with a prescriber and not a reason for alarm.
What compounded status means
Compounded medications are not FDA-approved. FDA's compounding questions-and-answers page, current as of 2025-09-16, says FDA does not approve compounded drugs, and that poor compounding practice can lead to contamination or the wrong amount of active ingredient. It also separates two kinds of facility. Pharmacies working under section 503A fill a prescription for an individual patient and are overseen mainly by state boards of pharmacy. Outsourcing facilities under section 503B register with FDA and are inspected on a risk basis.
The two lists above are why sermorelin's status is a matter of reading dates carefully. On the 503B side, FDA's document marks sermorelin acetate as a component of an FDA-approved drug and keeps it in Category 1, which is an interim enforcement category for substances still being evaluated. On the 503A side, the document updated 2026-05-14 does not list it. FDA's 503A page says a compounder may use a bulk substance that complies with a pharmacopeia monograph, that is a component of an approved drug where no monograph exists, or that is on the 503A bulks list. We did not find FDA stating whether sermorelin fits the "component of an approved drug" route, and we will not guess. Our compounded peptides page explains the 503A and 503B terms.
Two limits on what we can say. We did not locate FDA's own copy of the Geref label, so we do not list side effects from it. And we make no claim about what compounded sermorelin does for a person; FDA has not evaluated it, and neither have we.
Questions to ask before you pay
A prescriber or service can answer all of these in writing. If it cannot, that silence is information.
- Who prescribes, and are they licensed where I live? FDA's guidance starts with a licensed prescriber who reviews you.
- Which pharmacy fills it, and is it licensed in my state? Look up the license in your state board of pharmacy database, using FDA's BeSafeRx tool as a guide.
- Is it made by a 503A pharmacy or a 503B outsourcing facility? The answer changes who inspects it.
- What form is it, and what does FDA say about that form? A service may list injections, tablets or both. Ask about the specific product you would receive.
- Is it described as FDA-approved or "the same as" an approved drug? FDA lists claims of sameness as a red flag, so this is a warning sign in either direction.
- What does it cost, what renews automatically and how do I cancel? Get the answer in writing, with the renewal date.
- What does the label or packaging say? A label that says it is for research or not for human use is the wrong product for a person; see research peptides explained.
Where Whoosh Wellness fits
As stated by Whoosh (read 2026-10-07), it offers compounded sermorelin in injection and tablet forms through a questionnaire reviewed by a licensed physician, with prescriptions filled by licensed 503A or 503B US pharmacies. Whoosh does not name which pharmacy fills sermorelin, and its own pages disagree on several points; we list them in our Whoosh Wellness review.
A licensed physician decides whether a prescription is appropriate, so there is no promise of approval.
Other routes, and the one to avoid
Your own doctor can also prescribe, and a local state-licensed compounding pharmacy can fill it. The peptides near me page covers that. The route to avoid is a website that sells sermorelin as a "research" item with no prescription. FDA's GLP-1 page says it has warned companies that sell products labeled for research directly to consumers; research peptides explained covers that, and the source types overview compares all four routes.
Sources
- FDA: Federal Register notice 2013-04827, Geref determination published 2013-03-04, read 2026-10-07
- FDA: Bulk Drug Substances Nominated for Use in Compounding Under Section 503B updated 2025-03-21, read 2026-10-07
- FDA: Bulk Drug Substances Nominated for Use in Compounding Under Section 503A updated 2026-05-14, read 2026-10-07
- FDA: Bulk drug substances used in compounding under section 503A page current as of 2026-05-14, read 2026-10-07
- FDA: Compounding and FDA, questions and answers page current as of 2025-09-16, read 2026-10-07
- FDA: PCAC briefing document, October 29, 2024 read 2026-10-07
- FDA: Locate a state-licensed online pharmacy page current as of 2024-11-13, read 2026-10-07
- FDA: Concerns with unapproved GLP-1 drugs page current as of 2026-10-01, read 2026-10-07
- Whoosh Wellness: sermorelin product page as stated by Whoosh, read 2026-10-07
- Whoosh Wellness: FAQs as stated by Whoosh, read 2026-10-07
FAQ
Is sermorelin FDA-approved?
The brand Geref was approved in 1990 and 1997, and FDA withdrew those approvals effective 2009-06-18. Compounded sermorelin is not FDA-approved. FDA does not review compounded drugs for safety, effectiveness or quality before they are marketed.
Why was Geref discontinued?
The 2013 Federal Register notice records the maker's discontinuation letters from 2008 and says the products were not withdrawn for safety or effectiveness reasons. It does not state the maker's reason, so we do not offer one.
Can I buy sermorelin online without a prescription?
Not lawfully through the route FDA describes. FDA's wording is that a doctor writes the prescription and a state-licensed pharmacy fills it. A site that sells it without a prescriber is outside that route.
Is compounded sermorelin on FDA's bulk substance lists?
FDA's 503B document updated 2025-03-21 lists sermorelin acetate in Category 1. The 503A document updated 2026-05-14 has no entry for it that we found. We did not find an FDA statement on whether it fits the 503A "component of an approved drug" route.
Does Whoosh Wellness offer sermorelin?
Whoosh states that it offers compounded sermorelin (read 2026-10-07). Compounded medications are not FDA-approved, and Whoosh's own disclaimer says so. Our review covers what its pages state and where they disagree.
Does this page say sermorelin works?
No. We make no claim about what compounded sermorelin does. We report approval history, list status and the lawful route, each with a source and date.
Not medical advice. See the medical disclaimer.
